___

• 1.Olah KS, Gee H, Blunt S, Dunn JA, Chan KK. Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer 1991, 27: 1095-1099. 2.Levenbeck CF, Tortolero LG, Pandey DK, Malpica A, Baker VV, Whittaker L, Johnson E, Follen Mitchell M. Uterine Sarcoma In Follen Mitchell M, Schottenfeld D, Kitlong W (eds): Obstetrics and Gynecology Clinics of North America, Gynecologic Cancer Prevention, 1996, 23:457-473. 3. Page HS, Asire AJ. Cancer rates and risks. NIH Publication No: 85-691, Washington DC, US Department of Health and human Services, 1985. 4. Schwartz Z, Dgani R, Lancet M, Kesser I. Uterine sarcoma in Israel: a study of 104 cases. Gynecol Oncol 1985, 20: 354-363. , 5. Harlow BL, Weiss NS, Lofton S. The epidemiology of Sarcomas of the uterus. J Natl Cancer Inst 1986, 76: 399- 402. 6. Dihn TV, Slavin RE, Bhangavan BJ, Hannigan Ev, Tiamson EM, Yandell RB. Mixed Miillerian Tumors of the uterus: a clinicopathological study. Obstet Gynecol 1989,74:388-392. 7. Marchese MJ, Liskow AS, Crum CP. Uterine sarcoma. A clinicopathologic study 1965-1981. Gynecol Oncol 1984, 18: 299-304. 8. Cristopherson WM, Williamson EO, Gray LA. Leimyosarcoma of the uterus. Cancer 1972, 29: 1512- 1516. 9. Harlow BL, Weiss NS, Lofton S. The epidemiology of the sarcomas of the uterus. JNCI1986, 76:399. 10. Fenton AN, Burke L. Sarcoma of the uterus: A record of 26 cases. Am J Obstet Gynecol 1952, 63: 158. 11. Rose PG. Uterine sarcoma. In Piver MS(ed): The Handbook of Gynecologic Oncology. 2nd edition, Little Brown Co., Boston, 1996, 159. 12. Atasü T, Uludağ S, Girişken G. Endometrial Stromal Sarcoma. Cerrahpaşa Tıp Bülteni 1983, 15: 65-70. 13. Echt G, Jepson J, Steel J. Treatment of uterine sarcoma. Cancer 1990, 66: 35-39. 14. Harlow BL, Weiss NS, Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 1986, 76: 399- 402. 15. Laxman R, Currie JL, Kurman RJ et al. Cytogenetic profile of uterine sarcomas. Cancer 1993, 71: 1283. 16. Taina E, Maenpaa J, Erkkola R. Endometrial stromal sarcoma.A report of 9 cases. Gynecol Oncol 1989, 32: 156-162.
• 17. Crabtree T, Kempson RL, Hendrickson MR. Endometrial stromal sarcoma: a clinicopathological study of 56 cases. Lab Invest 1985, 52: 198. 18. Norris HJ, Taylor HB. Mesenchymal tumors of the uterus.I A clinicopathological study of 53 endometrial stromal tumors. Cancer 1966, 19: 755-766. 19. Malmstrom H, Schmidt H, Persson PG et al. Flowcytometric analysis of uterine sarcoma: ploidy ans S phase rate as prognostic indicators. Gynecol Oncol 1992, 44: 172. 20. Kahanpaa KV, Wahlstorm TA, Grohn P. Sarcomas of the uterus a clinopathological study of 119 patients. Obstet gynecol 1986, 67:417-424. 21. Piver MS, Rutledge FN, Copeland L et al. Uterine endolymphatic stromal myosis: a collaborative study. Obstet Gynecol 1984, 64:173. 22. Kuryak A, Kupesic S, Shalan H et al. Uterine sarcoma: a report of 10 cases studied by trans vaginal color and pulsed doppler sonography. Gynecol Oncol 1995, 59:342. 23. Pastner B, Mann WJ. Use of serum Ca. 125 in monitoring patients with uterine sarcoma: a preliminary report. Cancer 1988, 62: 1355. 24. Mansi JL, Ramachandura S, Wiltshaw E. Endometrial stromal sarcomas. Gynecol Oncol 1984,36: 113-118. 25. Salazar OM, Bonfiglio TA, Patten S. Uterine sarcomas: Natural history, treatment and prognosis. Cancer 1978, 42: 1152-1160. 26. Goff BA, Rice LW, Fleischhacker D. Uterine leiomyosarcoma and endometrial stromal sarcoma: Lymph node metastases and sites of recurrence. Gynecol Oncol 1993, 50: 105-109. 27. Edmonson JH, Ryan LM, Blum RH. Randomized comparison of doxorubicin alone versus ifofosfamide plus doxorubicin or mitomycin, doxorubicin and cisplatin against soft tissue sarcomas. J Clin Oncol 1993, 11: 1269-1275. '' 28. Montag TW, Manart FD. Endolymphatic stromal myosis: Surgical and hormonal theraphy for extensive venous recurrence. Gynecol Oncol 1989, 33: 255-260.